Skip to main content
. Author manuscript; available in PMC: 2008 Jan 7.
Published in final edited form as: J Immunother. 2005;28(1):53–62. doi: 10.1097/00002371-200501000-00007

FIGURE 3.

FIGURE 3

Comparison of T-cell persistence between the peripheral blood and tumor sites of melanoma patient 2098 after adoptive cell transfer. The TRBV sequences expressed in TIL 2098 as well as PBMC-6d, PBMC-27d, and PBMC-63d samples obtained at 6, 27, and 63 days following adoptive TIL 2098 transfer were compared with the TRBV sequences expressed in tumor samples obtained at 8, 29, and 64 days following adoptive TIL 2098 transfer, designated TU-d8, TU-d29, and TU-d64.